Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 25 of 26 entries
View as:

Simulated Driving Study in Restless Legs Syndrome

Phase: N/A Priority: Normal
NCT ID: NCT01332318 Org: User:
Start: 04/30/07 End: 11/30/07 Due: 11/30/08

XP13512 (Gabapentin Enacarbil) Extension Study in Patients With Restless Legs Syndrome.

Phase: N/A Priority: Normal
NCT ID: NCT00333359 Org: User:
Start: 06/30/06 End: 12/31/08 Due: 12/31/09

A Study to Evaluate the Safety and Tolerability of Arbaclofen Placarbil (XP19986) in Subjects With Acute Back Spasms

Phase: N/A Priority: Normal
NCT ID: NCT00817986 Org: User:
Start: 12/31/08 End: 07/31/09 Due: 07/31/10

An Exploratory Study of XP21279 (With Lodosyn®) and Sinemet® in Parkinson's Disease Subjects

Phase: N/A Priority: Normal
NCT ID: NCT00914602 Org: User:
Start: 05/31/09 End: 01/31/10 Due: 01/31/11

A Study to Evaluate the Effect of Gabapentin on Cardiac Repolarization in Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT01516372 Org: User:
Start: 01/31/12 End: 03/31/12 Due: 03/31/13

Drug Drug Interaction Study With Gabapentin Enacarbil and Morphine

Phase: N/A Priority: Normal
NCT ID: NCT01476124 Org: User:
Start: 08/31/11 End: 10/31/11 Due: 10/31/12

A Clinical Study in Subjects With Neuropathic Pain From PHN Who Have Had an Inadequate Response to Gabapentin Treatment

Phase: N/A Priority: Normal
NCT ID: NCT00617461 Org: User:
Start: 03/31/08 End: 07/31/09 Due: 07/31/10

A Safety and Efficacy Study of XP19986 in Subjects With Spasticity Due to Spinal Cord Injury

Phase: N/A Priority: Normal
NCT ID: NCT00557973 Org: User:
Start: 12/31/07 End: 04/30/09 Due: 04/30/10

An Extension Study to Evaluate the Efficacy and Safety of HORIZANT in Adolescents With Moderate-to-Severe Primary RLS

Phase: N/A Priority: Normal
NCT ID: NCT02633683 Org: User:
Start: 01/31/16 End: 07/31/24 Due: 07/31/25

XP13512 vs. Placebo in Patients With Restless Legs Syndrome.

Phase: N/A Priority: Normal
NCT ID: NCT00365352 Org: User:
Start: 08/31/06 End: 12/31/07 Due: 12/31/08

Polysomnography Study of GSK1838262 Extended Release Tablets Versus Placebo in RLS and Associated Sleep Disturbance

Phase: N/A Priority: Normal
NCT ID: NCT00748098 Org: User:
Start: 10/31/08 End: 07/31/09 Due: 07/31/10

Dose-Response and Pharmacokinetics of Gabapentin Enacarbil (GEn [XP13512 / GSK1838262]) in Restless Legs Syndrome

Phase: N/A Priority: Normal
NCT ID: NCT01332305 Org: User:
Start: 01/31/07 End: 01/31/08 Due: 01/31/09

A Efficacy, Safety and Pharmacokinetic Study of XP21279 and Sinemet® in Parkinson's Disease Subjects

Phase: N/A Priority: Normal
NCT ID: NCT01171313 Org: User:
Start: 07/31/10 End: 12/31/11 Due: 12/31/12

Study to Assess the Effect of Gabapentin Enacarbil on Simulated Driving in Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT01411124 Org: User:
Start: 06/30/11 End: 10/31/11 Due: 10/31/12

Long-Term Study of Gabapentin Enacarbil (GEn, XP13512) vs. Placebo in Patients With Restless Legs Syndrome.

Phase: N/A Priority: Normal
NCT ID: NCT00311363 Org: User:
Start: 04/30/06 End: 11/30/07 Due: 11/30/08

A Study In Patients With Neuropathic Pain From Post-Herpetic Neuralgia (PHN)

Phase: N/A Priority: Normal
NCT ID: NCT00619476 Org: User:
Start: 02/29/08 End: 07/31/09 Due: 07/31/10

Relative Bioavailability Study for GSK1838262 (Gabapentin Enacarbil)

Phase: N/A Priority: Normal
NCT ID: NCT00833391 Org: User:
Start: 01/31/09 End: 03/31/09 Due: 03/31/10

Efficacy and Safety of Arbaclofen Placarbil in Subjects With Spasticity Due to Multiple Sclerosis

Phase: N/A Priority: Normal
NCT ID: NCT01359566 Org: User:
Start: 05/31/11 End: 02/28/13 Due: 02/28/14

Gabapentin Enacarbil (GSK1838262) Adult Restless Leg Syndrome (RLS) Post Marketing Commitment Study

Phase: N/A Priority: Normal
NCT ID: NCT01668667 Org: User:
Start: 06/30/12 End: 11/30/13 Due: 11/30/14

An Efficacy and Safety Evaluation of HORIZANT in Adolescents With Moderate-to-Severe Primary RLS

Phase: N/A Priority: Normal
NCT ID: NCT02560766 Org: User:
Start: 02/29/16 End: 10/31/23 Due: 10/31/24

A PK and Safety Evaluation of HORIZANT (Gabapentin Enacarbil) in Adolescents With Moderate-to-Severe Primary RLS

Phase: N/A Priority: Normal
NCT ID: NCT02633657 Org: User:
Start: 01/31/16 End: 07/19/17 Due: 07/19/18

XP13512 (GSK1838262) Versus Placebo in Patients With Restless Legs Syndrome.

Phase: N/A Priority: Normal
NCT ID: NCT00298623 Org: User:
Start: 03/31/06 End: 02/28/07 Due: 02/28/08

Prevention Study in Adult Patients Suffering From Migraine Headaches

Phase: N/A Priority: Normal
NCT ID: NCT00742209 Org: User:
Start: 08/31/08 End: 06/30/10 Due: 06/30/11

A Study to Evaluate the Efficacy and Safety of Arbaclofen Placarbil (XP19986) as Adjunctive Therapy in Subjects With Gastroesophageal Reflux Disease (GERD)

Phase: N/A Priority: Normal
NCT ID: NCT00978016 Org: User:
Start: 09/30/09 End: 12/31/10 Due: 12/31/11

An Efficacy and Safety Study of XP19986 in Subjects With Symptomatic GERD

Phase: N/A Priority: Normal
NCT ID: NCT00557401 Org: User:
Start: 11/30/07 End: 09/30/08 Due: 09/30/09